These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 25947013)

  • 1. Increased expression of Solute carrier family 12 member 5 via gene amplification contributes to tumour progression and metastasis and associates with poor survival in colorectal cancer.
    Xu L; Li X; Cai M; Chen J; Li X; Wu WK; Kang W; Tong J; To KF; Guan XY; Sung JJ; Chan FK; Yu J
    Gut; 2016 Apr; 65(4):635-46. PubMed ID: 25947013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solute carrier family 12 member 5 promotes tumor invasion/metastasis of bladder urothelial carcinoma by enhancing NF-κB/MMP-7 signaling pathway.
    Liu JY; Dai YB; Li X; Cao K; Xie D; Tong ZT; Long Z; Xiao H; Chen MK; Ye YL; Liu B; Tan J; Tang J; Xu ZZ; Gan Y; Zhou YH; Deng F; He LY
    Cell Death Dis; 2017 Mar; 8(3):e2691. PubMed ID: 28333147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of SLC12A5 is associated with tumor progression and poor survival in ovarian carcinoma.
    Yang GP; He WP; Tan JF; Yang ZX; Fan RR; Ma NF; Wang FW; Chen L; Li Y; Shen HW; You ZS; Xie D; Yang GF
    Int J Gynecol Cancer; 2019 Oct; 29(8):1280-1284. PubMed ID: 31570543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solute carrier organic anion transporter family member 4A1 (SLCO4A1) as a prognosis marker of colorectal cancer.
    Ban MJ; Ji SH; Lee CK; Bae SB; Kim HJ; Ahn TS; Lee MS; Baek MJ; Jeong D
    J Cancer Res Clin Oncol; 2017 Aug; 143(8):1437-1447. PubMed ID: 28378090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of formin-like 3 contributes to metastasis and poor prognosis in colorectal carcinoma.
    Zeng YF; Xiao YS; Lu MZ; Luo XJ; Hu GZ; Deng KY; Wu XM; Xin HB
    Exp Mol Pathol; 2015 Apr; 98(2):260-7. PubMed ID: 25758200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of fibronectin is associated with poor prognosis, cell proliferation and malignancy via the NF-κB/p53-apoptosis signaling pathway in colorectal cancer.
    Yi W; Xiao E; Ding R; Luo P; Yang Y
    Oncol Rep; 2016 Dec; 36(6):3145-3153. PubMed ID: 27748871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
    Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
    Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CHD1L promotes tumor progression and predicts survival in colorectal carcinoma.
    Ji X; Li J; Zhu L; Cai J; Zhang J; Qu Y; Zhang H; Liu B; Zhao R; Zhu Z
    J Surg Res; 2013 Nov; 185(1):84-91. PubMed ID: 23746766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival.
    Schmid F; Wang Q; Huska MR; Andrade-Navarro MA; Lemm M; Fichtner I; Dahlmann M; Kobelt D; Walther W; Smith J; Schlag PM; Stein U
    Oncogene; 2016 Nov; 35(46):5942-5952. PubMed ID: 26686083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased urothelial cancer associated 1 is associated with tumor proliferation and metastasis and predicts poor prognosis in colorectal cancer.
    Ni B; Yu X; Guo X; Fan X; Yang Z; Wu P; Yuan Z; Deng Y; Wang J; Chen D; Wang L
    Int J Oncol; 2015 Oct; 47(4):1329-38. PubMed ID: 26238511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycystin-1 and polycystin-2 are involved in the acquisition of aggressive phenotypes in colorectal cancer.
    Gargalionis AN; Korkolopoulou P; Farmaki E; Piperi C; Dalagiorgou G; Adamopoulos C; Levidou G; Saetta A; Fragkou P; Tsioli P; Kiaris H; Zizi-Serbetzoglou A; Karavokyros I; Papavassiliou KA; Tsavaris N; Patsouris E; Basdra EK; Papavassiliou AG
    Int J Cancer; 2015 Apr; 136(7):1515-27. PubMed ID: 25123959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of DNAJB6 promotes colorectal cancer cell invasion through an IQGAP1/ERK-dependent signaling pathway.
    Zhang TT; Jiang YY; Shang L; Shi ZZ; Liang JW; Wang Z; Zhang Y; Hao JJ; Jia XM; Xu X; Cai Y; Zhan QM; Wang MR
    Mol Carcinog; 2015 Oct; 54(10):1205-13. PubMed ID: 25044025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased expression of SCUBE2 is associated with progression and prognosis in colorectal cancer.
    Song Q; Li C; Feng X; Yu A; Tang H; Peng Z; Wang X
    Oncol Rep; 2015 Apr; 33(4):1956-64. PubMed ID: 25672935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of protein phosphatase 4 is associated with the aggressive malignant behavior of colorectal carcinoma.
    Li X; Liang L; Huang L; Ma X; Li D; Cai S
    Mol Cancer; 2015 Apr; 14():95. PubMed ID: 25927939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of ANO9 in stage II and III colorectal carcinoma.
    Li C; Cai S; Wang X; Jiang Z
    Oncotarget; 2015 Oct; 6(30):29324-34. PubMed ID: 26317553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinesin 18A expression: clinical relevance to colorectal cancer progression.
    Nagahara M; Nishida N; Iwatsuki M; Ishimaru S; Mimori K; Tanaka F; Nakagawa T; Sato T; Sugihara K; Hoon DS; Mori M
    Int J Cancer; 2011 Dec; 129(11):2543-52. PubMed ID: 21213216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated expression of minichromosome maintenance 3 indicates poor outcomes and promotes G1/S cell cycle progression, proliferation, migration and invasion in colorectal cancer.
    Zhou H; Xiong Y; Zhang G; Liu Z; Li L; Hou S; Zhou T
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32597491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protocadherin 10 suppresses tumorigenesis and metastasis in colorectal cancer and its genetic loss predicts adverse prognosis.
    Jao TM; Tsai MH; Lio HY; Weng WT; Chen CC; Tzeng ST; Chang CY; Lai YC; Yen SJ; Yu SL; Yang YC
    Int J Cancer; 2014 Dec; 135(11):2593-603. PubMed ID: 24740680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membranous or Cytoplasmic HER2 Expression in Colorectal Carcinoma: Evaluation of Prognostic Value Using Both IHC & BDISH.
    Buhmeida A; Assidi M; Al-Maghrabi J; Dallol A; Sibiany A; Al-Ahwal M; Chaudhary A; Abuzenadah A; Al-Qahtani M
    Cancer Invest; 2018 Feb; 36(2):129-140. PubMed ID: 29504811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.